Director, Product Development
Shaun began his industrial career managing development teams and projects for Pfizer and GSK. He moved into the biotech sector in 2006, managing portfolios and product development for Syntaxin and ImmBio. Shaun went on to manage oncology R&D for Biosceptre and Inflection Biosciences as CSO. After obtaining a D.Phil. in cancer cell signalling, he undertook post-doctoral studies at the University of Cambridge researching receptor-mediated signalling and transcriptional regulation. He is a member of the American Society of Clinical Oncology and the American Association for Cancer Research.